UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Signaling by estrogens

Journal of cellular physiology, 2007-12, Vol.213 (3), p.610-617

2007

Volltextzugriff (PDF)

Pattern of Rash, Diarrhea, and Hepatic Toxicities Secondary to Lapatinib and Their Association With Age and Response to Neoadjuvant Therapy: Analysis From the NeoALTTO Trial

Journal of clinical oncology, 2013-12, Vol.31 (36), p.4504-4511

2013

Volltextzugriff (PDF)

Combinations of BRAF, MEK, and PI3K/mTOR inhibitors overcome acquired resistance to the BRAF inhibitor GSK2118436 dabrafenib, mediated by NRAS or MEK mutations

Molecular cancer therapeutics, 2012-04, Vol.11 (4), p.909-920

2012

Volltextzugriff (PDF)

A Phase I, Randomized, Multi‐Dose Study to Evaluate the Enteric Selectivity and Safety of JAK Inhibitor, Lorpucitinib, in Healthy Participants

Clinical pharmacology and therapeutics, 2024-05, Vol.115 (5), p.1075-1084

2024

Volltextzugriff (PDF)

Phosphorylation of MNAR Promotes Estrogen Activation of Phosphatidylinositol 3-Kinase

Molecular and Cellular Biology, 2007-03, Vol.27 (5), p.1904-1913

2007

Volltextzugriff (PDF)

Evidence that Stable Retroviral Transduction and Cell Survival following DNA Integration Depend on Components of the Nonhomologous End Joining Repair Pathway

Journal of Virology, 2004-08, Vol.78 (16), p.8573-8581

2004

Volltextzugriff (PDF)

Safety and clinical activity of JNJ-78306358, a human leukocyte antigen-G (HLA-G) x CD3 bispecific antibody, for the treatment of advanced stage solid tumors

Cancer Immunology, Immunotherapy : CII, 2024-08, Vol.73 (10), p.205, Article 205

2024

Volltextzugriff (PDF)

Evidence That the Retroviral DNA Integration Process Triggers an ATR-Dependent DNA Damage Response

Proceedings of the National Academy of Sciences - PNAS, 2003-04, Vol.100 (8), p.4778-4783

2003

Volltextzugriff (PDF)

The Cellular Protein Daxx Interacts with Avian Sarcoma Virus Integrase and Viral DNA To Repress Viral Transcription

Journal of Virology, 2005-04, Vol.79 (8), p.4610-4618

2005

Volltextzugriff (PDF)

High-Frequency Epigenetic Repression and Silencing of Retroviruses Can Be Antagonized by Histone Deacetylase Inhibitors and Transcriptional Activators, but Uniform Reactivation in Cell Clones Is Restricted by Additional Mechanisms

Journal of Virology, 2007-03, Vol.81 (6), p.2592-2604

2007

Volltextzugriff (PDF)

First-in-human, open-label, phase 1/2 study of the monoclonal antibody programmed cell death protein-1 (PD-1) inhibitor cetrelimab (JNJ-63723283) in patients with advanced cancers

Cancer chemotherapy and pharmacology, 2022-04, Vol.89 (4), p.499-514

2022

Volltextzugriff (PDF)

Histone H2AX Is Phosphorylated at Sites of Retroviral DNA Integration but Is Dispensable for Postintegration Repair

The Journal of biological chemistry, 2004-10, Vol.279 (44), p.45810-45814

2004

Volltextzugriff (PDF)

Human Immunodeficiency Virus Type 1 DNA Nuclear Import and Integration Are Mitosis Independent in Cycling Cells

Journal of Virology, 2003-12, Vol.77 (24), p.13412-13417

2003

Volltextzugriff (PDF)

Transduction of Interphase Cells by Avian Sarcoma Virus

Journal of Virology, 2002-06, Vol.76 (11), p.5422-5434

2002

Volltextzugriff (PDF)

Transduction of Terminally Differentiated Neurons by Avian Sarcoma Virus

Journal of Virology, 2004-05, Vol.78 (9), p.4902-4906

2004

Volltextzugriff (PDF)

Effects of cell cycle status on early events in retroviral replication

Journal of cellular biochemistry, 2005-04, Vol.94 (5), p.880-889

2005

Volltextzugriff (PDF)

Characterization of MNAR expression

Steroids, 2006-04, Vol.71 (4), p.317-322

2006

Volltextzugriff (PDF)

Lorpucitinib (JNJ-64251330) in patients with familial adenomatous polyposis (FAP): Results from a phase 1b study

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.10514-10514

2023

Volltextzugriff (PDF)

A Phase 1, Randomized, Multi-Dose Study to Evaluate the Enteric Selectivity and Safety of JAK Inhibitor, Lorpucitinib, in Healthy Participants

Clinical pharmacology and therapeutics, 2023-12

2023

Volltextzugriff (PDF)

Anti-PD-1 antibody cetrelimab (JNJ-63723283) in patients with advanced cancers: Updated phase I/II study results

Journal of clinical oncology, 2019-03, Vol.37 (8_suppl), p.31-31

2019

Volltextzugriff (PDF)

HumanImmunodeficiency Virus Type 1 DNA Nuclear Import and Integration AreMitosis Independent in CyclingCells

Journal of virology, 2003-12, Vol.77 (24), p.13412-13417

2003

Volltextzugriff (PDF)

Abstract 3627: Inhibition of HER family kinase signaling and tumor cell proliferation in non-EGFR and non-HER2 positive cell lines by lapatinib

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (8_Supplement), p.3627-3627

2010

Volltextzugriff (PDF)

Abstract 976: BRAF inhibitor GSK2118436 - single agent and combination activity with other targeted agents in BRAF V600 mutant melanoma

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.976-976

2012

Volltextzugriff (PDF)

Updated efficacy of the MEK inhibitor trametinib (T), BRAF inhibitor dabrafenib (D), and anti-EGFR antibody panitumumab (P) in patients (pts) with BRAF V600E mutated (BRAFm) metastatic colorectal cancer (mCRC)

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.103-103

2015

Volltextzugriff (PDF)

Abstract B71: Acquired resistance to the BRAF inhibitor GSK2118436, mediated by NRAS or MEK mutation, can be overcome with combinations that inhibit BRAF and MEK, BRAF and PI3K/mTOR, or MEK and PI3K/mTOR

Molecular cancer therapeutics, 2011-11, Vol.10 (11_Supplement), p.B71-B71

2011

Volltextzugriff (PDF)

1 – 25 von 42

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(41)

Publikationsform

Artikel
(41)
Reviews
(1)

Sprache

Englisch
(41)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(28)
Life Sciences & Biomedicine
(26)
Humans
(21)
Animals
(11)
Biological And Medical Sciences
(10)
Biochemistry & Molecular Biology
(8)
Female
(8)
Male
(7)
Hela Cells
(6)
Medical Sciences
(6)
Virology
(6)
Cell Biology
(5)
Adult
(4)
Aged
(4)
Dna, Viral - Metabolism
(4)
Fundamental And Applied Biological Sciences. Psychology
(4)
Genetic Vectors
(4)
Middle Aged
(4)
Oncology
(4)
Retroviridae - Genetics
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Signaling by estrogens

Pattern of Rash, Diarrhea, and Hepatic Toxicities Secondary to Lapatinib and Their Association With Age and Response to Neoadjuvant Therapy: Analysis From the NeoALTTO Trial

Combinations of BRAF, MEK, and PI3K/mTOR inhibitors overcome acquired resistance to the BRAF inhibitor GSK2118436 dabrafenib, mediated by NRAS or MEK mutations

A Phase I, Randomized, Multi‐Dose Study to Evaluate the Enteric Selectivity and Safety of JAK Inhibitor, Lorpucitinib, in Healthy Participants

Phosphorylation of MNAR Promotes Estrogen Activation of Phosphatidylinositol 3-Kinase

Evidence that Stable Retroviral Transduction and Cell Survival following DNA Integration Depend on Components of the Nonhomologous End Joining Repair Pathway

Safety and clinical activity of JNJ-78306358, a human leukocyte antigen-G (HLA-G) x CD3 bispecific antibody, for the treatment of advanced stage solid tumors

Evidence That the Retroviral DNA Integration Process Triggers an ATR-Dependent DNA Damage Response

The Cellular Protein Daxx Interacts with Avian Sarcoma Virus Integrase and Viral DNA To Repress Viral Transcription

High-Frequency Epigenetic Repression and Silencing of Retroviruses Can Be Antagonized by Histone Deacetylase Inhibitors and Transcriptional Activators, but Uniform Reactivation in Cell Clones Is Restricted by Additional Mechanisms

First-in-human, open-label, phase 1/2 study of the monoclonal antibody programmed cell death protein-1 (PD-1) inhibitor cetrelimab (JNJ-63723283) in patients with advanced cancers

Histone H2AX Is Phosphorylated at Sites of Retroviral DNA Integration but Is Dispensable for Postintegration Repair

Human Immunodeficiency Virus Type 1 DNA Nuclear Import and Integration Are Mitosis Independent in Cycling Cells

Transduction of Interphase Cells by Avian Sarcoma Virus

Transduction of Terminally Differentiated Neurons by Avian Sarcoma Virus

Effects of cell cycle status on early events in retroviral replication

Characterization of MNAR expression

Lorpucitinib (JNJ-64251330) in patients with familial adenomatous polyposis (FAP): Results from a phase 1b study

A Phase 1, Randomized, Multi-Dose Study to Evaluate the Enteric Selectivity and Safety of JAK Inhibitor, Lorpucitinib, in Healthy Participants

Anti-PD-1 antibody cetrelimab (JNJ-63723283) in patients with advanced cancers: Updated phase I/II study results

HumanImmunodeficiency Virus Type 1 DNA Nuclear Import and Integration AreMitosis Independent in CyclingCells

Abstract 3627: Inhibition of HER family kinase signaling and tumor cell proliferation in non-EGFR and non-HER2 positive cell lines by lapatinib

Abstract 976: BRAF inhibitor GSK2118436 - single agent and combination activity with other targeted agents in BRAF V600 mutant melanoma

Updated efficacy of the MEK inhibitor trametinib (T), BRAF inhibitor dabrafenib (D), and anti-EGFR antibody panitumumab (P) in patients (pts) with BRAF V600E mutated (BRAFm) metastatic colorectal cancer (mCRC)

Abstract B71: Acquired resistance to the BRAF inhibitor GSK2118436, mediated by NRAS or MEK mutation, can be overcome with combinations that inhibit BRAF and MEK, BRAF and PI3K/mTOR, or MEK and PI3K/mTOR

Suchergebnisse filtern